Table 1.
Maternal Baseline Characteristics
| Amlodipine (n=48) | Other Antihypertensives (n=54) | No Antihypertensives (n=129) | P Value | |
|---|---|---|---|---|
| Age at delivery (y)—mean (SD) | 37.5 (4.04) | 37.9 (5.04) | 36.3 (4.27) | 0.047 |
| Height, cm—mean (SD) | 158.3 (4.62) | 159.0 (4.64) | 159.0 (5.98) | 0.727 |
| Prepregnancy body weight, kg—mean (SD) | 62.2 (13.03) | 66.4 (14.92) | 67.9 (17.10) | 0.107 |
| Prepregnancy BMI, kg/m2—mean (SD) | 24.8 (5.02) | 26.4 (6.34) | 26.8 (6.42) | 0.153 |
| Nulliparous, N (%) | 20 (41.7) | 26 (48.1) | 70 (54.3) | 0.310 |
| Underlying disease | ||||
| Diabetes mellitus, N (%) | 3 (6.3) | 1 (1.9) | 6 (4.7) | 0.533 |
| Thyroid disease, N (%) | 7 (14.6) | 4 (7.4) | 5 (3.9) | 0.044 |
| Kidney disease, N (%) | 3 (6.3) | 0 (0.0) | 4 (3.1) | 0.184 |
| Collagen disease, N (%) | 4 (8.3) | 2 (3.7) | 2 (1.6) | 0.090 |
| Congenital heart disease, N (%) | 0 (0.0) | 0 (0.0) | 1 (0.8) | 0.672 |
| Previous pregnancy complications | ||||
| Hypertensive disorders of pregnancy, N (%) | 19 (39.6) | 10 (18.5) | 28 (21.7) | 0.024 |
| Fetal growth restriction, N (%) | 10 (20.8) | 5 (9.3) | 7 (5.4) | 0.008 |
| Smoking during pregnancy, N (%) | 0 (0.0) | 3 (5.6) | 5 (3.9) | 0.287 |
| Alcohol consumption during pregnancy, N (%) | 0 (0.0) | 1 (1.9) | 2 (1.6) | 0.662 |
BMI indicates body mass index.